share_log

UroGen Pharma Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%), etc.

乌龙制药 | SC 13D/A:超过5%持股股东披露文件(修正)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%)等

美股SEC公告 ·  2024/11/18 19:19
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息